Director, Clinical Development search
The person who owns the science of the study day to day. A hybrid role that fails when it is specified as either purely scientific or purely operational.
Director of Clinical Development sits in an awkward and important place: senior enough to own the scientific content of a study, close enough to the work to be in the weekly operational calls. The candidates who do it well are hybrids, and hybrids are hard to find with a keyword search because their resumes look like two different people.
What we actually assess
- Protocol authorship. Genuinely writing sections, defending endpoints, and handling the amendment when the design meets reality, rather than reviewing a CRO draft.
- Scientific credibility with investigators. Whether a site PI takes them seriously on a call, which is not something a title confers.
- Data review discipline. Ongoing blinded data review, safety signal awareness, and knowing when something needs escalation.
- Translation to operations. The ability to explain to a CTM why an inclusion criterion matters, and to hear back that it will halve the enrollment rate, and to resolve that rather than escalate it.
- Cross-functional stamina. This role lives between medical, operations, biometrics, and safety. Being right is not sufficient.
Where these searches go wrong
Specifying only half the job
A spec written by the CMO describes a scientist. A spec written by the head of operations describes a program manager. Written by both without reconciliation, it describes someone who does not exist. This is the single biggest cause of a stalled Director of Clinical Development search.
Screening out the CRO background
Some of the strongest candidates for this role come from medical or scientific leadership at a CRO, where they have seen twenty protocols instead of three. Sponsor-only filters remove them automatically.
Confusing it with medical monitoring
They overlap and they are not the same job. If the role requires medical monitoring, that changes both the degree requirement and the pool, and it should be settled before sourcing rather than at interview stage.
How we run it
We reconcile the scientific and operational halves of the spec with both stakeholders before mapping the market, because that conversation usually reveals which half is genuinely non-negotiable. Then we approach directly across sponsor and CRO backgrounds, assess for the hybrid rather than for either pure profile, and present a short list with honest notes on where each person leans.
Questions about this search
Is this role the same as a medical monitor?
No, though they overlap and are sometimes combined. Medical monitoring carries patient-level medical accountability and usually requires an MD. Director of Clinical Development can be a PhD or PharmD role. Deciding which you need before sourcing saves weeks.
Should we consider candidates from a CRO?
Often yes. CRO-side medical and scientific leads have typically worked across far more protocols and sponsors than a same-level sponsor candidate. The thing to test is decision authority, because at a CRO they advise more than they decide.
What if we are not sure whether we need a Director or a VP?
That usually resolves quickly by looking at who owns the development plan. If someone above this person owns the strategy, it is a Director role. If this person is the strategy, it is a VP role and should be paid like one.
Related searches
Is this the role that has not moved?
Send us the spec and the history. You will get an honest read on the pool and on what is holding it up.
Let us look at the search
Tell us the role, the level, and how long it has been open. If it is one we can fill, you will know quickly. If it is not, you will hear that too.